Sensory Profiles in School-Aged Children with Autism Spectrum Disorder: A Descriptive Study Using the Sensory Processing Measure-2 (SPM-2).

Autism Spectrum Disorders Sensory Processing Measure children sensory profile

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
17 Mar 2022
Historique:
received: 31 01 2022
revised: 10 03 2022
accepted: 15 03 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 26 3 2022
Statut: epublish

Résumé

Background: Sensory reactivity is considered one of the diagnostic criteria for Autism Spectrum Disorders (ASD) and has been associated with poorer functional outcomes, behavioral difficulties, and autism severity across the lifespan. The characterization of the sensory processing in ASD has thus become crucial to identify the sensory and motor features influencing the development of personal autonomy. Objectives: The present study has two aims: (1) to compare the sensory processing between school-aged children with ASD and typically developing peers (TD); (2) to evaluate whether, within the ASD sample, the cognitive level and reported sensory symptoms explain the scores exhibited at the Sensory Processing Measure (SPM-2). Methods: The SPM-2 test was administered to the parents of 105 children with ASD and 70 TD. The ASD group was further subdivided into two groups, namely high and low functioning based on their cognitive level (High Functioning (HF), IQ > 80; Low Functioning (LF), IQ < 80). Results: ASD children exhibited higher scores throughout the SPM-2 total score and its multiple subscales. Within ASD, while HF and LF children did not differ in terms of the SPM-2 total score, a significant difference was found for the hearing, social participation, and balance and motion subscales. Conclusions: Aside from classical knowledge that the ASD population suffers from sensory processing disorders, we revealed that different sensory patterns are associated with high or low cognitive functioning. Beyond its neurobiological interest, such knowledge may be of fundamental importance for individualizing psychoeducational interventions in preschool- and school-aged children and later developmental stages.

Identifiants

pubmed: 35329994
pii: jcm11061668
doi: 10.3390/jcm11061668
pmc: PMC8955781
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Italian Ministry of Health; and by Tuscany Region
ID : &quot;5 × 1000&quot; voluntary contributions; and (ACCESS - POR FSE - 2014-2020)

Références

Trends Cogn Sci. 2012 Oct;16(10):504-10
pubmed: 22959875
Autism Res. 2010 Feb;3(1):8-18
pubmed: 20063319
Int J Psychophysiol. 2008 May;68(2):170-5
pubmed: 18304666
J Child Psychol Psychiatry. 2006 Jun;47(6):591-601
pubmed: 16712636
Bioengineering (Basel). 2022 Jan 20;9(2):
pubmed: 35200402
Dev Med Child Neurol. 1979 Oct;21(5):656-9
pubmed: 389718
Folia Psychiatr Neurol Jpn. 1982;36(4):367-74
pubmed: 7169196
Am J Occup Ther. 1997 Jul-Aug;51(7):530-7
pubmed: 9242859
Brain Sci. 2017 Aug 19;7(8):
pubmed: 28825635
Eur Arch Psychiatry Neurol Sci. 1989;238(3):169-74
pubmed: 2721535
Cognition. 2017 Sep;166:459-465
pubmed: 28476357
J Autism Dev Disord. 1991 Sep;21(3):303-13
pubmed: 1938776
Brain Lang. 1989 Jul;37(1):26-41
pubmed: 2473824
Compr Psychiatry. 1970 Mar;11(2):159-73
pubmed: 4314258
J Neurodev Disord. 2015;7(1):24
pubmed: 26203305
Biol Psychiatry. 2009 Jan 1;65(1):15-6
pubmed: 19064037
Am J Occup Ther. 2007 Mar-Apr;61(2):216-27
pubmed: 17436844
J Autism Dev Disord. 1994 Jun;24(3):247-57
pubmed: 8050980
J Autism Dev Disord. 2019 Dec;49(12):4974-4996
pubmed: 31501953
J Autism Dev Disord. 2009 Jan;39(1):1-11
pubmed: 18512135
Am J Occup Ther. 2007 Mar-Apr;61(2):135-40
pubmed: 17436834
J Autism Dev Disord. 1995 Feb;25(1):61-70
pubmed: 7608035
Autism. 2007 Mar;11(2):123-34
pubmed: 17353213
J Autism Dev Disord. 2015 Jan;45(1):230-44
pubmed: 25245785
J Autism Dev Disord. 2015 Feb;45(2):395-405
pubmed: 23963591
Phys Occup Ther Pediatr. 2015;35(4):365-80
pubmed: 25374155
Nat Rev Neurosci. 2017 Nov;18(11):671-684
pubmed: 28951611
Front Integr Neurosci. 2021 Sep 29;15:743561
pubmed: 34658804
Am J Occup Ther. 1998 Apr;52(4):283-90
pubmed: 9544354
Am J Occup Ther. 2007 Mar-Apr;61(2):190-200
pubmed: 17436841
Am J Occup Ther. 1997 Jul-Aug;51(7):500-7
pubmed: 9242855
Am J Occup Ther. 1997 Feb;51(2):91-5
pubmed: 9124275
Am J Occup Ther. 2004 May-Jun;58(3):287-93
pubmed: 15202626
J Autism Dev Disord. 2003 Dec;33(6):643-52
pubmed: 14714933
J Child Psychol Psychiatry. 1990 Sep;31(6):921-34
pubmed: 2246342
Neuropediatrics. 1984 Feb;15(1):33-6
pubmed: 6608698
Autism. 2014 May;18(4):428-32
pubmed: 24085741
Front Neurosci. 2016 Jun 17;10:268
pubmed: 27378838
Dev Med Child Neurol. 1996 Mar;38(3):191-202
pubmed: 8631516
Neurology. 1969 Jul;19(7):653-8
pubmed: 5815129
J Autism Dev Disord. 1999 Jun;29(3):213-24
pubmed: 10425584
BMJ. 1996 Feb 10;312(7027):327-8
pubmed: 8611819
J Autism Dev Disord. 2017 Aug;47(8):2519-2534
pubmed: 28527095
Front Psychol. 2014 May 21;5:379
pubmed: 24904448
J Autism Dev Disord. 2003 Dec;33(6):631-42
pubmed: 14714932
Prog Neurobiol. 2015 Nov;134:140-60
pubmed: 26455789
Psychother Psychosom. 2008;77(5):271-9
pubmed: 18560252
Brain Sci. 2020 Oct 13;10(10):
pubmed: 33066155
J Autism Dev Disord. 2009 Jul;39(7):1087-91
pubmed: 19283461
Autism. 2019 Jul;23(5):1210-1223
pubmed: 30354191

Auteurs

Antonio Narzisi (A)

Department of Child Psychiatry and Psychopharmacology, IRCCS Stella Maris Foundation, 56128 Pisa, Italy.

Maddalena Fabbri-Destro (M)

Institute of Neuroscience, National Research Council (CNR), 43125 Parma, Italy.

Giulia Crifaci (G)

Institute of Neuroscience, National Research Council (CNR), 43125 Parma, Italy.

Stefano Scatigna (S)

Department of Child Psychiatry and Psychopharmacology, IRCCS Stella Maris Foundation, 56128 Pisa, Italy.

Federica Maugeri (F)

Child Neurology and Psychiatry Section, Department of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy.

Stefano Berloffa (S)

Department of Child Psychiatry and Psychopharmacology, IRCCS Stella Maris Foundation, 56128 Pisa, Italy.

Pamela Fantozzi (P)

Department of Child Psychiatry and Psychopharmacology, IRCCS Stella Maris Foundation, 56128 Pisa, Italy.

Adriana Prato (A)

Child Neurology and Psychiatry Section, Department of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy.

Rosy Muccio (R)

Department of Child Psychiatry and Psychopharmacology, IRCCS Stella Maris Foundation, 56128 Pisa, Italy.

Elena Valente (E)

Department of Child Psychiatry and Psychopharmacology, IRCCS Stella Maris Foundation, 56128 Pisa, Italy.

Valentina Viglione (V)

Department of Child Psychiatry and Psychopharmacology, IRCCS Stella Maris Foundation, 56128 Pisa, Italy.

Edoardo Pecchini (E)

Department of Child Psychiatry and Psychopharmacology, IRCCS Stella Maris Foundation, 56128 Pisa, Italy.

Susanna Pelagatti (S)

Department of Computer Science, University of Pisa, Largo Pontecorvo 3, 56127 Pisa, Italy.

Renata Rizzo (R)

Child Neurology and Psychiatry Section, Department of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy.
Research Unit of Rare Diseases and Neurodevelopmental Disorders, Oasi Research Institute-IRCCS, 94018 Troina, Italy.

Annarita Milone (A)

Department of Child Psychiatry and Psychopharmacology, IRCCS Stella Maris Foundation, 56128 Pisa, Italy.

Rita Barone (R)

Child Neurology and Psychiatry Section, Department of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy.

Gabriele Masi (G)

Department of Child Psychiatry and Psychopharmacology, IRCCS Stella Maris Foundation, 56128 Pisa, Italy.

Classifications MeSH